ER/LA Opioid REMS Course - presented by WCAAHEC and ASAM

The CO*RE/ASAM ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care Course


The misuse of extended-release and long-acting (ER/LA) opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:

  • In 2011, almost 17,000 Americans died of drug overdose involving opioid analgesics.

  • 1 in 20 high school seniors reports abusing OxyContin.

The FDA approved a risk evaluation and mitigation strategy (REMS) for ER/LA opioid medications on July 9, 2012. The CO*RE/ASAM ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care course was developed by nationally renowned experts from Collaborative for REMS Education (CO*RE) and incorporates all six units defined by the FDA blueprint for REMS education. ASAM also provides a unit addressing ER/LA opioids and addiction.

Course Outline

  • Assessing Patients for Treatment with ER/LA Opioid Analgesic Therapy

  • Initiating Therapy, Modifying Dosing, and Discontinuing Use of ER/LA Opioid Analgesics

  • Managing Therapy with ER/LA Opioid Analgesics

  • Counseling Patients & Caregivers about Safe Use of ER/LA Opioid Analgesics

  • General Drug Information for ER/LA Opioid Analgesics

  • Specific Drug Information for ER/LA Opioid Analgesic Products

  • Is My Patient Opioid Addicted? – Diagnosis and Management

*This course is not intended to advocate for the use of ER/LA Opioids, but to ensure proper education about safe prescribing practices should a medical provider determine that ER/LA Opioids are the best course of treatment. 

Target Audience

The intended audience is all prescribers of ER/LA Opioids which includes: pain specialists, primary care physicians, physician assistants, nurse practitioners, advanced practice nurses, dentists, addiction medicine physicians, psychiatrists and other physicians and clinicians. 

CME Information

The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

The American Society of Addiction Medicine designates this enduring material for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.


Presented by ASAM, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.

RPC Commercial Support Disclosure Statement

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see this link for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

Questions? Contact ASAM’s Education Department

American Society of Addiction Medicine
4601 North Park Avenue
Upper Arcade, Suite 101
Chevy Chase, MD 20815-4520
Education Department
Phone: 301-656-3920 | Fax: 301-656-3815 | Email: | Web:

Instructions for the Course

This is a recorded tapping from the 3rd Annual Community Mental Health Summit, sponsored by the Tuscaloosa Veterans Affairs Medical Center in partnership with the American Society of Addiction Medicine (ASAM) and the West Central Alabama Area Health Education Center (AHEC). The course is divided into two modules - each lasting approximately 1.5 hours. Following the completion of the second module, a short evaluation and post-test is required in order to claim CME. CME Certificates/Certificates of Completion will only be emailed to individuals who complete the entirety of the course & evaluation. Certificates will be emailed within two weeks. 

In order to view the videos, you must create a login specific to this course only and complete the registration form. Please note: this login is different than the login for the online learning courses on the AL-MS PHTC website. 

To create a new account, proceed to Module 1. Once you are on this page, click register. You will be required to create a username and enter an email address. Once you have hit create new account, a welcome message will be sent to your email address with instructions on how to create a password and login to your account. YOU MUST FIRST SELECT A PASSWORD BEFORE LOGGING INTO THE ACCOUNT. Use the link in the email to select the password. Once you have created a password, you are ready to take the course. 

This course offering will expire on December 31, 2016. 

Learning Objectives

  • Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy, as well as possible misuse.

  • Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques, as well as appropriate discontinuation strategies.

  • Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects.

  • Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.

  • Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids.


Click Here for Course Materials

Click Here to Proceed to Module 1